Polio virus detected in children without symptoms: What does it really mean?
On May 9, 2025, health officials in Papua New Guinea reported to the World Health Organization (WHO) that they found a type of poliovirus called circulating
vaccine-derived poliovirus
type 2 (
cVDPV2
) in stool samples from two healthy kids in Lae City, Morobe Province.
These samples were part of a routine check after an earlier environmental sample from April 4 showed traces of the virus.
The kids didn't show any symptoms, but the virus was present in their systems.
What is a vaccine-derived virus? The
oral polio vaccine
(OPV) contains a weakened version of the virus to help build immunity. In rare cases, especially in areas with low vaccination coverage, this weakened virus can circulate in the community and mutate over time.
If it changes enough, it can cause illness just like the wild virus. That's what's referred to as vaccine-derived poliovirus.
Why is this a threat?
Even though the kids were healthy, the presence of cVDPV2 indicates that the virus is circulating in the community. This is concerning because Papua New Guinea has low vaccination rates, especially in certain provinces. For instance, in Morobe Province, the coverage for the third dose of the oral polio vaccine (OPV3) was just 44% in 2024.
Low vaccination rates mean more people are susceptible to the virus, increasing the risk of an outbreak.
Poliovirus can cause a wide range of symptoms from nothing at all to very serious illness. About 70% of people infected with poliovirus don't feel sick at all. They carry the virus but show no signs. Mild symptoms like fever, sore throat, headache, fatigue, nausea, stomach pain usually appear 3 to 7 days after exposure and go away on their own.
In about 1 in 200 to 1 in 2,000 cases, the virus invades the nervous system, which can lead to Meningitis (inflammation of the brain and spinal cord lining), stiffness in the neck, back pain, and headaches and Paresthesia (pins and needles feeling in the legs or arms).
Even after recovery, some develop post-polio syndrome decades later, with muscle weakness, fatigue and joint pain.
About 70% of polio infections are completely asymptomatic.
That means the person carries the virus and can spread it to others, but they don't feel sick at all. Around 24% of infected people get mild symptoms.
This looks like the flu, fever, sore throat, fatigue, and maybe a headache or upset stomach. These cases usually go away in a few days and often go unnoticed.
Even if someone has no symptoms, they can still shed the virus in their stool and spread it—especially in places with poor sanitation or low vaccine coverage. So in short: Most people who get polio don't know they have it—but they can still pass it on. That's what makes surveillance and vaccination super important.
One step to a healthier you—join Times Health+ Yoga and feel the change
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
3 hours ago
- India.com
COVID-19 Cases In India: Active Cases Rise To 5,364; Delhi 592 - Kerala Leading With 1,679 Cases; 4 Deaths In 24 Hours
COVID 19 Cases Rising In India Live Updates: India is once again witnessing an unsettling rise in COVID-19 cases, with the number of active infections climbing to 5,364; according to the Ministry of Health and Family Welfare's latest update as of 8:00 AM IST, June 7, 2025. Leading the current spike is Kerala, with 192 fresh infections, pushing its active caseload to 1,679; nearly half of the country's total. Meanwhile, West Bengal added 58 new cases, increasing its active tally to 596, while the national capital Delhi, recorded 30 new infections, taking its active cases to 592. Maharashtra, another state that has seen consistent rises in previous waves, reported 22 new COVID-19 cases, bringing the total number of infections recorded to 548, as per the state's public health department. As per May 2025 classifications by the World Health Organization (WHO), subvariants LF.7 and NB.1.8.1 are categorized as Variants Under Monitoring, meaning they are not yet deemed as Variants of Concern or Variants of Interest. However, these strains are suspected to be contributing to the rising infections not just in India but also across China and other parts of Asia. Despite the emergence of new subvariants, the JN.1 strain remains the most dominant, accounting for a staggering 53% of all positive cases across the country. According to data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG), a case of NB.1.8.1 was detected in Tamil Nadu in April, while four cases of LF.7 were identified in Gujarat earlier this month. With the virus subtly shifting form and symptoms evolving, health authorities are urging the public to maintain precautionary measures, including hygiene, mask use in crowded places, and timely testing. Although hospitalisation remains low, experts warn that complacency could reverse progress. Stay informed, and if you're experiencing mild symptoms like fatigue, a sore throat, or gastrointestinal discomfort, it's best to test early and isolate to prevent further spread. Say Tuned To Zee News For Latest Updates...
Indian Express
4 hours ago
- Indian Express
Measles spike in US shows how vaccine hesitancy threatens decades of public-health progress
Vaccines are critical tools for the containment and elimination of infectious diseases. They work not merely by protecting individuals, but by reducing community transmission. There have been several global pushes to improve vaccine uptake over the years, but one major coordinated effort occurred in 2021 in response to the Covid pandemic, which saw the most rapid vaccine introduction in history. Globally, the years with the most vaccine introductions have typically coincided with public health initiatives, funding boosts, or as a response to pandemics. The 1980s and 1990s saw WHO's Expanded Programme on Immunisation (EPI) with DTP (diphtheria-tetanus-pertussis), polio, measles, BCG (tuberculosis) vaccines and Hepatitis B and Hib vaccines introduced in the late 1990s. The 2000s saw accelerated introductions of Hepatitis B, Haemophilus influenzae type B (Hib), and yellow fever vaccines in low-income countries, marking a shift in global access to routine vaccines. The introduction of new and underused vaccines like pneumococcal conjugate vaccine (PCV), rotavirus vaccine, HPV and Measles-Rubella (MR) vaccine marked the next decade. The United States is currently experiencing a significant resurgence of measles, with 1,046 confirmed cases as of May 27. This marks a sharp increase from previous years, with the majority of cases occurring among unvaccinated individuals in regions with declining immunisation rates. Measles was officially eliminated from the US in 2000. This implies that new cases occur only when someone contracts measles abroad and returns to the country. A new study from Johns Hopkins points out that the significant drop in childhood vaccination rates is concerning because herd immunity requires at least 95 per cent vaccination coverage. The MMR vaccine is probably one of the most effective vaccines. A single dose gives 93 per cent protection from infection, and two doses up to 98 per cent. Measles, which can be deadly for unvaccinated children, is highly contagious. Factors like post-pandemic vaccine hesitancy, non-evidence-based fears of the association between the MMR vaccine and autism, and the complacency of populations who may not remember the long-term sequelae of measles infection are behind the dwindling measles vaccination rates in the US. Measles is often regarded as the 'canary in the coalmine' — if cases spread, it is a warning that other disease outbreaks might spring up where there are gaps in vaccination coverage. Its resurgence in the US is a global warning that even advanced health systems are vulnerable without consistent immunisation. Globally, only 83 per cent of children received the first dose of the measles vaccine in 2023; 74 per cent received the second dose. These figures fall short of the 95 per cent coverage needed to prevent outbreaks. India has made significant strides in its immunisation efforts, particularly under the UIP. India achieved a national immunisation coverage of 93.5 per cent in 2023–24, indicating that the majority of children received all recommended vaccines by the age of two. Since its inception, Mission Indradhanush, focused on areas with low immunisation rates, has completed 12 phases, vaccinating 5.46 crore children and 1.32 crore pregnant women across 554 districts. However, the measles upsurge in the US shows one cannot ignore increasing vaccine hesitancy, particularly since it threatens to throw away the gains made in the containment of infectious diseases. In resource-limited settings, this can lead to healthcare systems being overwhelmed and a general delay in uptake of new vaccines. Misinformation has contributed significantly to the declining uptake for vaccines. The flu vaccination rates among NHS staff in the UK, for instance, dropped to their lowest in nearly 15 years in 2024-25. So far, India has remained immune to vaccine hesitancy. Previous experience with successful vaccination campaigns and government endorsements have played an important role in creating a positive perception of vaccines. However, we must remain alert and actively consider putting in place a multi-pronged, culturally nuanced plan to address vaccine hesitancy. The writer is senior scientist, ICMR
Time of India
8 hours ago
- Time of India
NO2 levels in city's air three times higher than safe limits
Gurgaon: Concentration of nitrogen dioxide (NO2) -- a pollutant emitted by burning fuel in vehicles, power plants and industries – exceeded the maximum safe limit by three times in the past two days. Data from the Gwal Pahari air quality monitoring station showed that average NO2 for eight hours was 133µg/m³ on Thursday and 123µg/m³ on Friday. In India, the safe limit for exposure to NO2 is 40µg/m³. The maximum concentration considered safe by the World Health Organization is even lower, at 25 µg/m³. Experts said emissions from vehicles, especially in congested areas, is likely to be the key reason for NO2 pollution. They said NO2 does not get as much regulatory attention as other pollutants such as particulate matter (PM2.5 and PM10), though it is associated with exacerbating respiratory ailments. Shubhansh Tiwari, a research associate at the Centre for Science and Environment (CSE), said on Friday, "Elevated NO₂ levels in the city are predominantly due to vehicular emissions. Old vehicles and traffic congestion are key sources of NO2 here." by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo Asked about action taken to reduce NO2 emissions, an official of the Haryana State Pollution Control Board (HSPCB) said the agency has allowed a private firm to scrap old vehicles. "This aims to remove polluting vehicles from city roads," the official said. A senior HSPCB official said NO2 levels are likely to have spiked after brief relief due to pre-monsoon showers. "The recent rains had kept nitrogen dioxide levels in check by dispersing pollutants. But with clear skies and calmer weather now, NO2 from vehicular and industrial emissions is building up, especially in traffic-dense areas. Unlike particulate matter, NO2 often flies under the radar, but prolonged exposure can be equally hazardous," the official said. Currently, just one of the four air quality monitoring stations is functioning in the city. Dr Bandana Mishra, who heads the pulmonology and respiratory medicine department at Manipal Hospital in Gurgaon said everyone is at risk from high NO2 exposure, but children and the elderly suffer the most. "Nitrogen dioxide exposure can lead to increased inflammation of the airways, which results in persistent cough wheezing, reduced lung function and a higher frequency of asthma attacks," Dr Mishra said. Get the latest lifestyle updates on Times of India, along with Eid wishes , messages , and quotes !
